Zerr, Pawel <br/><br/>
Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.  [electronic resource] 

 -  The American journal of pathology  Nov 2012 
 - 1672-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-2191 
<br/><br/><label>Standard No.: </label>10.1016/j.ajpath.2012.07.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides<br/>Chronic Disease<br/>Dermis--drug effects<br/>Disease Models, Animal<br/>Drug Therapy, Combination<br/>Female<br/>Fibrosis<br/>Graft vs Host Disease--drug therapy<br/>Humans<br/>Imatinib Mesylate<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Middle Aged<br/>Piperazines--pharmacology<br/>Proto-Oncogene Proteins c-abl--antagonists & inhibitors<br/>Pyrimidines--pharmacology<br/>Receptors, Platelet-Derived Growth Factor--antagonists & inhibitors<br/>Scleroderma, Systemic--drug therapy<br/>Signal Transduction--drug effects